Literature DB >> 15931687

Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis.

Katja U Schneider1, Antonio Marchini, Nitin Sabherwal, Ralph Röth, Beate Niesler, Tiina Marttila, Rüdiger J Blaschke, Margaret Lawson, Miroslav Dumic, Gudrun Rappold.   

Abstract

Haploinsufficiency of the short stature homeobox gene SHOX has been found in patients with idiopathic short stature (ISS) and Leri-Weill dyschondrosteosis (LWD). In addition to complete gene deletions and nonsense mutations, several missense mutations have been identified in both patient groups, leading to amino acid substitutions in the SHOX protein. The majority of missense mutations were found to accumulate in the region encoding the highly conserved homeodomain of the paired-like type. In this report, we investigated nine different amino acid exchanges in the homeodomain of SHOX patients with ISS and LWD. We were able show that these mutations cause an alteration of the biological function of SHOX by loss of DNA binding, reduced dimerization ability, and/or impaired nuclear translocation. Additionally, one of the mutations (c.458G>T, p.R153L) is defective in transcriptional activation even though it is still able to bind to DNA, dimerize, and translocate to the nucleus. Thus, we demonstrate that single missense mutations in the homeodomain fundamentally impair SHOX key functions, thereby leading to the phenotype observed in patients with LWD and ISS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931687     DOI: 10.1002/humu.20187

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.

Authors:  Gudrun Rappold; Werner F Blum; Elena P Shavrikova; Brenda J Crowe; Ralph Roeth; Charmian A Quigley; Judith L Ross; Beate Niesler
Journal:  J Med Genet       Date:  2006-12-20       Impact factor: 6.318

2.  Identification of a Gypsy SHOX mutation (p.A170P) in Léri-Weill dyschondrosteosis and Langer mesomelic dysplasia.

Authors:  Verónica Barca-Tierno; Miriam Aza-Carmona; Eva Barroso; Damia Heine-Suner; Dimitar Azmanov; Jordi Rosell; Begoña Ezquieta; Lucia Sentchordi Montané; Teresa Vendrell; Jaime Cruz; Fernando Santos; José Ignacio Rodríguez; Jesús Pozo; Jesús Argente; Luba Kalaydjieva; Ricardo Gracía; Angel Campos-Barros; Sara Benito-Sanz; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2011-06-29       Impact factor: 4.246

3.  Clinical utility gene card for: Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD).

Authors:  Juliette Albuisson; Sébastien Schmitt; Sabine Baron; Stéphane Bézieau; Sara Benito-Sanz; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

4.  Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division.

Authors:  Cheryl Shoubridge; May Huey Tan; Tod Fullston; Desiree Cloosterman; David Coman; George McGillivray; Grazia M Mancini; Tjitske Kleefstra; Jozef Gécz
Journal:  Pathogenetics       Date:  2010-01-05

5.  Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox gene.

Authors:  Stephen R F Twigg; Sarah L Versnel; Gudrun Nürnberg; Melissa M Lees; Meenakshi Bhat; Peter Hammond; Raoul C M Hennekam; A Jeannette M Hoogeboom; Jane A Hurst; David Johnson; Alexis A Robinson; Peter J Scambler; Dianne Gerrelli; Peter Nürnberg; Irene M J Mathijssen; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2009-04-30       Impact factor: 11.025

6.  Tbx4 interacts with the short stature homeobox gene Shox2 in limb development.

Authors:  Anne Glaser; Ripla Arora; Sandra Hoffmann; Li Li; Norbert Gretz; Virginia E Papaioannou; Gudrun A Rappold
Journal:  Dev Dyn       Date:  2014-01-28       Impact factor: 3.780

Review 7.  A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Authors:  Antonio Marchini; Tsutomu Ogata; Gudrun A Rappold
Journal:  Endocr Rev       Date:  2016-06-29       Impact factor: 19.871

8.  Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency.

Authors:  Antonino Montalbano; Lonny Juergensen; Ralph Roeth; Birgit Weiss; Maki Fukami; Susanne Fricke-Otto; Gerhard Binder; Tsutomu Ogata; Eva Decker; Gudrun Nuernberg; David Hassel; Gudrun A Rappold
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

9.  NPPB and ACAN, two novel SHOX2 transcription targets implicated in skeletal development.

Authors:  Miriam Aza-Carmona; Veronica Barca-Tierno; Alfonso Hisado-Oliva; Alberta Belinchón; Darya Gorbenko-del Blanco; Jose Ignacio Rodriguez; Sara Benito-Sanz; Angel Campos-Barros; Karen E Heath
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

10.  Identification of novel SHOX target genes in the developing limb using a transgenic mouse model.

Authors:  Katja U Beiser; Anne Glaser; Kerstin Kleinschmidt; Isabell Scholl; Ralph Röth; Li Li; Norbert Gretz; Gunhild Mechtersheimer; Marcel Karperien; Antonio Marchini; Wiltrud Richter; Gudrun A Rappold
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.